alexa Pneumococcal Polysaccharide Vaccine | Germany| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Pneumococcal Polysaccharide Vaccine

  • Pneumococcal Polysaccharide Vaccine

    Disease definition: Pneumococcal polysaccharide vaccine (PPSV)—the latest version is known as Pneumovax 23 (PPV-23)—is the first pneumococcal vaccine, the first vaccine derived from a capsular polysaccharide, and an important landmark in medical history. The polysaccharide antigens were used to induce type-specific antibodies that enhanced opsonization, phagocytosis, and killing of Streptococcus pneumoniae (pneumococcal) bacteria by phagocytic immune cells.

  • Pneumococcal Polysaccharide Vaccine

    Symptoms: "Less serious side effects are more likely to occur, such as: low fever (102 degrees or less), chills, tired feeling; swelling, pain, tenderness, or redness anywhere on your body; headache, nausea, vomiting; joint or muscle pain; swelling or stiffness in the arm or leg the vaccine was injected into; mild skin rash."

  • Pneumococcal Polysaccharide Vaccine

    Disease Treatment: " Antibiotics can be used for treatment. However, some pneumococcal bacteria have become “antibiotic resistant” and antibiotics no longer kill them. Antibiotic resistance makes it very hard to treat some pneumococcal infections.

  • Pneumococcal Polysaccharide Vaccine

    Statistics:"Death rate of Pneumococcal (Pneumococcal Polysaccharide Vaccine)patients per 100,000 was found to be 1.21% during the year 2014 "

Expert PPTs
Speaker PPTs

High Impact List of Articles

Conference Proceedings